For the quarter ending 2025-09-30, GOSS has $208,820K in assets. $291,153K in debts. $8,933K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 8,933 | 26,309 | ||
| Marketable securities | 171,291 | 186,609 | ||
| Receivable from contracts with collaborators | 9,243 | 7,579 | ||
| Prepaid expenses and other current assets | 14,522 | 15,401 | ||
| Total current assets | 203,989 | 235,898 | ||
| Property and equipment, net | 70 | 76 | ||
| Operating lease right-of-use assets | 4,354 | 4,568 | ||
| Other assets | 407 | 383 | ||
| Total assets | 208,820 | 240,925 | ||
| Accounts payable | 1,116 | 1,876 | ||
| Accrued research and development expenses | 17,736 | 15,601 | ||
| Current contract liabilities | 23,974 | 23,472 | ||
| Accrued expenses and other current liabilities | 19,291 | 12,645 | ||
| Total current liabilities | 62,117 | 53,594 | ||
| Long-term convertible senior notes | 198,257 | 198,009 | ||
| Operating lease liabilities - long-term | 3,700 | 3,934 | ||
| Long-term contract liabilities | 27,079 | 31,495 | ||
| Total liabilities | 291,153 | 287,032 | ||
| Common stock, 0.0001 par value 700,000,000 shares authorized as of september30, 2025 and december31, 2024 231,306,125 shares issued and outstanding as of september30, 2025, and 226,604,138 shares issued and outstanding as of december31, 2024 | 24 | 23 | ||
| Additional paid-in capital | 1,314,450 | 1,302,437 | ||
| Accumulated deficit | -1,391,700 | -1,343,479 | ||
| Accumulated other comprehensive income (loss) | -5,107 | -5,088 | ||
| Total stockholders' equity (deficit) | -82,333 | -46,107 | ||
| Total liabilities and stockholders' equity | 208,820 | 240,925 | ||
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)